Reuters logo
BRIEF-Kitov boosts ownership in Tyrnovo and Oncology platform
October 6, 2017 / 1:25 PM / 2 months ago

BRIEF-Kitov boosts ownership in Tyrnovo and Oncology platform

Oct 6 (Reuters) - Kitov Pharmaceuticals Holdings Ltd

* Kitov boosts ownership in Tyrnovo and Oncology platform through exchange of shares for stock

* Kitov Pharmaceuticals Holdings Ltd - ‍Acquires an additional 27% ownership stake in Tyrnovo and NT219, its oncology therapeutic candidate​

* Kitov Pharmaceuticals Holdings-‍After closing of transaction, Kitov will hold approximately 92% of Tyrnovo’s issued and outstanding ordinary shares​

* Kitov - ‍Acquires additional ownership stake in Tyrnovo and NT219 in exchange for Kitov stock at a value of $2.50 per ads​

* Kitov - To acquire Tyrnovo shares from unaffiliated minority shareholders​ based on agreed upon Tyrnovo valuation of $7 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below